December 19, 2025

Integrating Mental Health Into Cancer Care: A Community Oncology Imperative

When Julie began chemotherapy for breast cancer, her oncologist adjusted antiemetics weekly and carefully tracked neutrophil counts. Still, no one asked about the panic attacks that kept her awake at ...

The ASCO Post

December 09, 2025

Hear, Hear to ‘Advancing Geriatric Oncology: Where We Have Been and Where We Are Going’

We read with interest the commentary by Stuart Lichtman, MD, FASCO,on “Advancing Geriatric Oncology: Where We Have Been and Where We Are Going,“ in the October 25, 2025 issue of The ASCO Post.1 Dr. Li...

The ASCO Post

December 09, 2025

The Diagnosis I Couldn’t Deliver: An Oncologist’s Journey Between Roles

As a medical oncologist and palliative care physician, I have spent years preparing for difficult conversations. I’ve guided patients and families through the uncertainty of cancer, helped them naviga...

The ASCO Post

December 09, 2025

ASTRO Marks Former President Biden’s Prostate Cancer Treatment Milestone

The American Society for Radiation Oncology (ASTRO) congratulates former President Joe Biden on completing his course of radiation therapy, which he marked by ringing the ceremonial bell alongside his...

The ASCO Post

December 05, 2025

How the Proliferation of Fraudulent Scientific Papers Is Threatening the Integrity of Cancer Research

There is a perception among many scientists that scientific fraud is a rare occurrence, resulting from the actions of a few isolated bad actors. However, an extensive investigation by Reese A.K. Richa...

The ASCO Post

December 04, 2025

ASCO Statement on the Departure of Richard Pazdur, MD, From the FDA

Dr. Pazdur has served the FDA for 26 years and is an expert in drug regulation. He is a longtime ASCO member who has been recognized with the ASCO Service Recognition Award and ASCO Public Service Awa...

The ASCO Post

November 21, 2025

Reducing the Barriers to Receiving CAR T-Cell Therapy for Patients With Hematologic Malignancies

Chimeric antigen receptor (CAR) T-cell therapy has transformed treatment for patients with hematologic malignancies, achieving unprecedented responses in some patients, especially those diagnosed with...

The ASCO Post

November 20, 2025

Realizing the Full Potential of Patient Engagement in Clinical Research

Nothing about us without us is a centuries-old value that is a cornerstone of meaningful patient engagement in clinical research. Such engagement has not been automatic and is still largely absent in ...

The ASCO Post

November 18, 2025

My 50 Years in Lymphoma: Lessons Learned?

In the 50 years now since my fellowship training, there have been major advances in the diagnosis, staging, prognostic scoring, treatment, and response assessment of lymphomas. To conjure up the futur...

The ASCO Post